SENSEX
NIFTY 50
Hang Seng
Taiwan Weighted
MCX GOLD FEB 05
MCX SILVER MAR 05
USD/INR
EUR/INR80.0630

SENSEX
NIFTY 50
NIFTY MIDCAP 100
S&P BSE MIDCAP
Hang Seng
Taiwan Weighted
DAX
Nasdaq
MCX GOLD FEB 05
MCX SILVER MAR 05
MCX CRUDEOIL FEB 19
MCX NATURALGAS JAN 25
USD/INR
EUR/INR
GBP/INR
JPY/INR

Market Highlights: Sensex rallies 834 points, Nifty ends above 14,500 led by metals, banks

Global Markets: Asia shares pare losses as China economy rebounds

Oil prices extend gains after US inventory drop

Wrapping 2020 with a subtle depreciation- What’s on the cards for the Rupee in 2021?

cipla

Cipla settles patent litigation for cancer drug Revlimid with Celgene in US

Cipla settles patent litigation for cancer drug Revlimid with Celgene in US

By Ekta Batra

view more

Videos on cipla

Cipla will continue to perform well; Lupin, DRL will see good growth coming in, says Sanford Bernstein

Cipla will continue to perform well; Lupin, DRL will see good growth coming in, says Sanford Bernstein

By Latha Venkatesh , Sonia Shenoy , Anuj Singhal

Standout Brokerage Report: Bernstein positive on pharmaceutical sector

Standout Brokerage Report: Bernstein positive on pharmaceutical sector

By Nimesh Shah

Cipla settles patent litigation for cancer drug Revlimid with Celgene in US

Cipla settles patent litigation for cancer drug Revlimid with Celgene in US

By Ekta Batra

Positive on Burger King; like Ipca, Divi's Labs & Cipla, says Complete Circle Consultants

Positive on Burger King; like Ipca, Divi's Labs & Cipla, says Complete Circle Consultants

By Sonia Shenoy , Latha Venkatesh , Surabhi Upadhyay

Looking at quarterly run rate of $140 mn in US market: Cipla

Looking at quarterly run rate of $140 mn in US market: Cipla

By Latha Venkatesh , Sonia Shenoy , Anuj Singhal

more news

Cipla inks licensing deal with Belgium's MultiG for distribution of COVID-19 antibody test kit

Cipla inks licensing deal with Belgium's MultiG for distribution of COVID-19 antibody test kit

By PTI

Looking at quarterly run rate of $140 mn in US market: Cipla

Looking at quarterly run rate of $140 mn in US market: Cipla

By Latha Venkatesh , Sonia Shenoy , Anuj Singhal

Trending on CNBC-TV18

Live TV

recommended for you